GREAT WEST LIFE ASSURANCE CO /CAN/ - MYRIAD GENETICS INC ownership

MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 193 filers reported holding MYRIAD GENETICS INC in Q3 2020. The put-call ratio across all filers is 0.87 and the average weighting 0.1%.

Quarter-by-quarter ownership
GREAT WEST LIFE ASSURANCE CO /CAN/ ownership history of MYRIAD GENETICS INC
ValueSharesWeighting
Q3 2023$1,524
-31.0%
95,099
-0.1%
0.00%
-20.0%
Q2 2023$2,209
-3.1%
95,155
-3.2%
0.01%
-16.7%
Q1 2023$2,279
+50.5%
98,289
-5.8%
0.01%
+50.0%
Q4 2022$1,514
-99.9%
104,315
+2.2%
0.00%
-33.3%
Q3 2022$1,948,000
+31.1%
102,066
+24.7%
0.01%
+50.0%
Q2 2022$1,486,000
-19.8%
81,847
+14.2%
0.00%0.0%
Q1 2022$1,852,000
-4.1%
71,694
+2.4%
0.00%0.0%
Q4 2021$1,932,000
-12.1%
69,983
+3.6%
0.00%
-20.0%
Q3 2021$2,199,000
+6.1%
67,569
-0.6%
0.01%0.0%
Q2 2021$2,072,000
+2.2%
67,946
+2.1%
0.01%0.0%
Q1 2021$2,028,000
+36.7%
66,547
-11.4%
0.01%
+66.7%
Q4 2020$1,484,000
+32.5%
75,068
-12.7%
0.00%
+50.0%
Q3 2020$1,120,000
+4.6%
86,027
-9.0%
0.00%0.0%
Q2 2020$1,071,000
-25.3%
94,489
-5.8%
0.00%
-50.0%
Q1 2020$1,434,000
-43.1%
100,335
+7.4%
0.00%
-20.0%
Q4 2019$2,522,000
-6.6%
93,393
-3.9%
0.01%
-16.7%
Q2 2019$2,700,000
-17.3%
97,224
-1.2%
0.01%
-33.3%
Q1 2019$3,264,000
+22.8%
98,381
-0.8%
0.01%
+12.5%
Q4 2018$2,658,000
-35.2%
99,142
+11.1%
0.01%
-20.0%
Q3 2018$4,102,000
+20.2%
89,198
-2.4%
0.01%
+25.0%
Q2 2018$3,414,000
+24.6%
91,382
-1.5%
0.01%
+14.3%
Q1 2018$2,740,000
-12.2%
92,760
+2.0%
0.01%0.0%
Q4 2017$3,121,000
-9.1%
90,902
-4.2%
0.01%
-22.2%
Q3 2017$3,434,000
+32.2%
94,886
-5.8%
0.01%
+28.6%
Q2 2017$2,598,000
+38.9%
100,694
+3.3%
0.01%
+40.0%
Q1 2017$1,870,000
+1114.3%
97,514
+958.4%
0.01%
Q4 2016$154,000
-59.3%
9,213
-50.0%
0.00%
-100.0%
Q3 2016$378,000
+34.5%
18,426
+100.0%
0.00%0.0%
Q2 2016$281,000
-18.6%
9,2130.0%0.00%0.0%
Q1 2016$345,000
+22.3%
9,213
+40.9%
0.00%0.0%
Q4 2015$282,000
+14.6%
6,5390.0%0.00%0.0%
Q3 2015$246,000
+10.8%
6,5390.0%0.00%0.0%
Q2 2015$222,000
-3.9%
6,5390.0%0.00%0.0%
Q1 2015$231,000
+49.0%
6,539
+43.4%
0.00%0.0%
Q4 2014$155,000
-12.4%
4,5600.0%0.00%0.0%
Q3 2014$177,000
-0.6%
4,560
-0.8%
0.00%0.0%
Q2 2014$178,000
+14.8%
4,596
+0.8%
0.00%0.0%
Q1 2014$155,000
+61.5%
4,5600.0%0.00%
Q4 2013$96,0004,5600.00%
Other shareholders
MYRIAD GENETICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
SCOPIA CAPITAL MANAGEMENT LP 6,459,139$278,776,0005.53%
Tieton Capital Management, LLC 119,290$5,149,0004.04%
RPg Family Wealth Advisory, LLC 97,202$4,195,238,0003.85%
RK Capital 384,900$16,612,0002.90%
Contrarius Investment Management Ltd 652,288$28,153,0002.65%
S&T BANK/PA 331,885$14,324,0002.22%
Euclidean Technologies Management, LLC 40,917$1,766,0001.90%
AIMZ Investment Advisors, LLC 45,635$1,970,0001.80%
Taylor Frigon Capital Management LLC 34,783$1,486,0001.67%
KILLEN GROUP INC 366,305$15,810,0001.63%
View complete list of MYRIAD GENETICS INC shareholders